About the Cancer Consortium

The Fred Hutchinson/University of Washington Cancer Consortium is a research collaboration comprising Fred Hutch and its strong collaborators, the University of Washington, Seattle Children's, and the Seattle Cancer Care Alliance.  The Consortium is recognized as an NCI-designated Comprehensive Cancer Center through its dedication to developing research programs, faculty, and facilities that will lead to better approaches to prevention, diagnosis, and treatment of cancer.

The Consortium brings together over 620 faculty with interests in basic science, clinical and translational research,  public health sciences, and global health related to cancer.


Partner Institutions

The four participating institutions in the Fred Hutch/University of Washington Cancer Consortium collaborate across the disciplines of basic, clinical and public health sciences.  

Learn more about Consortium partners »


Consortium Leadership

Dr. Gary Gilliland serves as director of the Cancer Consortium and principal investigator of the Cancer Center Support Grant.

Read more about Dr. Gilliland


The Cancer Center Support Grant is a P30 award from the National Cancer Institute that supports Consortium infrastructure and scientific goals.

Find out more about Consortium research priorities.

Clinical Trials & Research Studies

If you would like information on current trials or research studies being conducted at the Consortium's partner institutions, use the following search tools. 

Collaborative Clinical Research

Within the Consortium there are several NIH-supported clinical research programs emphasizing collaboration between laboratory and clinical scientists. Learn more »

Menu Search